COMPASS Pathways Plc

News & Events

Press Releases

In The Media

1. Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

   Business Wire MAY 14, 2025 6:30 AM EDT
   Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient ac...
   READ ARTICLE

2. Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

   Business Wire MAY 8, 2025 6:30 AM EDT
   Highlights: 6-week top-line data from Part A of COMP005 phase 3 trial in treatment resi...
   READ ARTICLE

3. Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

   Business Wire APR 29, 2025 6:30 AM EDT
   Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient ac...
   READ ARTICLE

4. Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

   Business Wire APR 28, 2025 6:30 AM EDT
   Compass management will host a conference call at 8:00 am ET (1:00 pm UK) Compass Pat...
   READ ARTICLE

5. Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

   Business Wire APR 22, 2025 6:00 AM EDT
   Highlights: Participants received a single dose of either 25 mg of COMP360 or placebo O...
   READ ARTICLE

6. Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

   Business Wire MAR 26, 2025 6:30 AM EDT
   Highlights: Screening closed for all sites and final participants being scheduled for d...
   READ ARTICLE

7. Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

   Business Wire MAR 18, 2025 6:30 AM EDT
   Highlights: 52-week observational follow-up study from Phase 2b reveals single 25 mg CO...
   READ ARTICLE

8. Compass Pathways to Participate in Stifel Virtual CNS Forum

   Business Wire MAR 11, 2025 6:30 AM EDT
   Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient ac...
   READ ARTICLE

9. Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

   Business Wire FEB 27, 2025 6:30 AM EST
   Highlights: Phase 3 COMP005 trial in participants with treatment resistant depression (...
   READ ARTICLE

10. Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

    Business Wire FEB 25, 2025 4:00 PM EST
    Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient ac...
    READ ARTICLE